Literature DB >> 28829753

"Fishing" out the real VEGFs.

Tatiana V Byzova1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 28829753      PMCID： PMC5106111          DOI： 10.1182/blood-2016-09-737023

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

Review 1.  The role of VEGF in the regulation of physiological and pathological angiogenesis.

Authors:  Napoleone Ferrara
Journal:  EXS       Date:  2005

2.  Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in mice.

Authors:  Ajay K Malik; Megan E Baldwin; Franklin Peale; Germaine Fuh; Wei-Ching Liang; Henry Lowman; Gloria Meng; Napoleone Ferrara; Hans-Peter Gerber
Journal:  Blood       Date:  2005-09-27       Impact factor: 22.113

3.  PlGF blockade does not inhibit angiogenesis during primary tumor growth.

Authors:  Carlos Bais; Xiumin Wu; Jenny Yao; Suya Yang; Yongping Crawford; Krista McCutcheon; Christine Tan; Ganesh Kolumam; Jean-Michel Vernes; Jeffrey Eastham-Anderson; Peter Haughney; Marcin Kowanetz; Thijs Hagenbeek; Ian Kasman; Hani Bou Reslan; Jed Ross; Nick Van Bruggen; Richard A D Carano; Yu-Ju Gloria Meng; Jo-Anne Hongo; Jean-Philippe Stephan; Masabumi Shibuya; Napoleone Ferrara
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

4.  Regulation of Vegf signaling by natural and synthetic ligands.

Authors:  Andrea Rossi; Sebastien Gauvrit; Michele Marass; Luyuan Pan; Cecilia B Moens; Didier Y R Stainier
Journal:  Blood       Date:  2016-08-24       Impact factor: 22.113

5.  Autocrine VEGF signaling is required for vascular homeostasis.

Authors:  Sunyoung Lee; Tom T Chen; Chad L Barber; Maria C Jordan; Jared Murdock; Sharina Desai; Napoleone Ferrara; Andras Nagy; Kenneth P Roos; M Luisa Iruela-Arispe
Journal:  Cell       Date:  2007-08-24       Impact factor: 41.582

6.  Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels.

Authors:  Christian Fischer; Bart Jonckx; Massimiliano Mazzone; Serena Zacchigna; Sonja Loges; Lucia Pattarini; Emmanuel Chorianopoulos; Laurens Liesenborghs; Marta Koch; Maria De Mol; Monica Autiero; Sabine Wyns; Stephane Plaisance; Lieve Moons; Nico van Rooijen; Mauro Giacca; Jean-Marie Stassen; Mieke Dewerchin; Desire Collen; Peter Carmeliet
Journal:  Cell       Date:  2007-11-02       Impact factor: 41.582

Review 7.  Resistance to antiangiogenic therapies.

Authors:  Marco Bartolotti; Enrico Franceschi; Rosalba Poggi; Alicia Tosoni; Monica Di Battista; Alba A Brandes
Journal:  Future Oncol       Date:  2014-06       Impact factor: 3.404

Review 8.  Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders.

Authors:  Aernout Luttun; Marc Tjwa; Peter Carmeliet
Journal:  Ann N Y Acad Sci       Date:  2002-12       Impact factor: 5.691

9.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.

Authors:  N Ferrara; K Carver-Moore; H Chen; M Dowd; L Lu; K S O'Shea; L Powell-Braxton; K J Hillan; M W Moore
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

10.  Implications of Increase in Vascular Permeability in Tumors by VEGF: A Commentary on the Pioneering Work of Harold Dvorak.

Authors:  Mark W Dewhirst; Kathleen A Ashcraft
Journal:  Cancer Res       Date:  2016-06-01       Impact factor: 12.701
  10 in total
  2 in total

Review 1.  COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.

Authors:  David M Smadja; Steven J Mentzer; Michaela Fontenay; Mike A Laffan; Maximilian Ackermann; Julie Helms; Danny Jonigk; Richard Chocron; Gerald B Pier; Nicolas Gendron; Stephanie Pons; Jean-Luc Diehl; Coert Margadant; Coralie Guerin; Elisabeth J M Huijbers; Aurélien Philippe; Nicolas Chapuis; Patrycja Nowak-Sliwinska; Christian Karagiannidis; Olivier Sanchez; Philipp Kümpers; David Skurnik; Anna M Randi; Arjan W Griffioen
Journal:  Angiogenesis       Date:  2021-06-28       Impact factor: 9.596

2.  Microvascular dysfunction in COVID-19: the MYSTIC study.

Authors:  Alexandros Rovas; Irina Osiaevi; Konrad Buscher; Jan Sackarnd; Phil-Robin Tepasse; Manfred Fobker; Joachim Kühn; Stephan Braune; Ulrich Göbel; Gerold Thölking; Andreas Gröschel; Hermann Pavenstädt; Hans Vink; Philipp Kümpers
Journal:  Angiogenesis       Date:  2020-10-14       Impact factor: 10.658
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.